Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04417504
Other study ID # MobFood
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2020
Est. completion date October 31, 2020

Study information

Verified date November 2019
Source Universidade do Porto
Contact Conceição Calhau, PhD
Phone 00351 218803035
Email ccalhau@nms.unl.pt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The mobilizing programme MobFood - mobilizing scientific knoweledge and technology to answer the current nutrition market challenges - is formed by a consortium of 47 collaborative entities, between the industry and ENESIIs (Entidades Não Empresariais do Sistema de Investigação e Inovação) and is financed by Structural European Funds of Investment.

The project is currently investigating and undertaking collaborative scientific and technological strategies based on R&D and innovation, in order to boost and promote a more competitive national food industry, capable of overcoming the current challenges, including those of the Millennial Generation. This group is particularly conscious of the impact of food behaviour and food choices on health but extremely vulnerable to dietary imbalance. Strategies to improve Millenials' nutrition while providing conscious food products are needed.

This study is a randomised, cross-over controlled trial designed to test the metabolic effect, particularly in terms of appetite control and glycaemic response of a breakfast kit (nutritionally balanced and innovative), recently developed as part of the collaborative project MobFood_PPS4.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 15
Est. completion date October 31, 2020
Est. primary completion date September 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 23 Years to 38 Years
Eligibility Inclusion Criteria:

- Male or female;

- Born between 1981 and 1996;

- Body mass index (BMI) between 18.5 kg/m2 and 24.9 kg/m2;

- Normoglycemic according to American Diabetes Association criteria [Fasting Plasma Glucose < 100 mg/dl, 2-h plasma glucose value during a 75 g oral glucose tolerance test (OGTT) < 140 mg/dl)];

- Healthy.

Exclusion Criteria:

- Overweight or obese (BMI = 25,0 kg/m2);

- Recent body weight loss/gain >10%, within previous 3 months;

- Being on a weight loss/other special diet (e.g. Paleo diet, Atkins diet, flexitarian diet or ketogenic diet), within previous 3 months;

- Clinically significant illness, including:

type 1 or type 2 diabetes; liver disease e.g. cirrhosis; malignancy; pancreatitis or other malabsorption; gastrointestinal disorders e. g. intestinal bowel disorder, celiac disease; previous weight loss surgery e.g. bariatric surgery; chronic respiratory, neurological, psychiatric, musculoskeletal diseases/conditions; diagnosed eating disorders.

- Individuals who don't regularly consume breakfast;

- Having taken antibiotics within the 12 weeks prior to beginning the study;

- Taking other medication that could potentially affect body weight, glucose metabolism and/or appetite (e.g. GLP-1 analogues);

- Being engaged in competitive sports;

- Having >14 or >8 (males and females, respectively) alcoholic units/week; misuse of drugs;

- Having donated blood within one month prior to the beginning of the study;

- Nut or milk allergy, or other food allergy or intolerance that would compromise compliance with the study protocol;

- Pregnant or breastfeeding.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MobFood breakfast kit
Cereal biscuit with orange fruit, cheese with fruit preparation and beverage based on oat, milk and mocha (without added sugar), specifically developed for the project MobFood_PPS4.
Control isocaloric breakfast
White bread, butter and milk.

Locations

Country Name City State
Portugal NOVA Medical School, NOVA University of Lisbon Lisbon

Sponsors (3)

Lead Sponsor Collaborator
Universidade do Porto Center for Health Technology and Services Research, NOVA Medical School

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differences in the incremental area under the curve (iAUC, mg/dl*min) for glucose response between the 2 arms The iAUC for glucose will be calculated based on the concentration curve following consumption of the test and control products, over 2h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Primary Differences in the iAUC (pmol/l*min) for glucagon-like peptide-1 (GLP-1) between the 2 arms The iAUC for GLP-1 will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Primary Differences in the iAUC (pmol/l*min) for peptide YY (PYY) between the 2 arms The iAUC for PYY will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Primary Differences in the iAUC (pmol/l*min) for cholecystokinin (CKK) between the 2 arms The iAUC for CKK will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Primary Differences in the iAUC (pmol/l*min) for ghrelin between the 2 arms The iAUC for ghrelin will be calculated based on the concentration curve following consumption of test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Primary Differences in the iAUC (pmol/l*min) for glucagon between the 2 arms The iAUC for glucagon will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Secondary Differences in the iAUC (mg/dl*min) for triacylglycerides (TG) between 2 arms The iAUC for TG will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Secondary Differences in the iAUC for (mmol/l*min) non-esterified fatty acids (NEFA) between 2 arms The iAUC for NEFA will be calculated based on the concentration curve following consumption of the test and control products, over 3h at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
Secondary Differences in subjective feelings of hunger/satiety between the 2 arms Difference in subjective feelings of hunger/satiety from fasting state to post-prandial state with the consumption of the test and control products at CID1 (1 week after screening) and CID2 (at least 2 days after visit 1)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Completed NCT04025099 - Internal Cues Versus External Cues for Eating and Activity N/A
Completed NCT04766528 - Effect of Diet on the Microbiota / Endoccanabinoidome Axis in Response to Physical Activity N/A
Completed NCT03277040 - Diet, Eating, and Lifestyle Improvement for Valued Employees and Their Relatives N/A
Active, not recruiting NCT05544461 - Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students N/A
Active, not recruiting NCT04748835 - The SEEA (SCI Energy Expenditure and Activity) Study
Active, not recruiting NCT04991142 - Models of Nutrition From Continuous Glucose Monitors
Recruiting NCT04487015 - A Digital Approach to Improving Carbohydrate Periodisation Behaviours in Athlete: SMART+ Study N/A
Completed NCT03748056 - Targeted Food Incentives to Improve Diet Quality and Health Among Adults N/A
Not yet recruiting NCT05960396 - Exploring the Mechanism of Dietary Pattern Improving MAFLD N/A
Enrolling by invitation NCT04314882 - The Danish National Survey of Diet and Physical Activity 2021-2023
Terminated NCT04677322 - TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
Completed NCT03855098 - Biomarkers of Food Intake Using a Cross-over Feeding Study N/A
Completed NCT03124446 - Mindfulness-Based College: Stage 1 N/A
Completed NCT03993652 - Kids FIRST: Family-based Intervention to Reduce Snacking and Screen Time in Children N/A
Completed NCT04766034 - Impact of Behavioral Economic Strategies on Low-Income Older Adults' Food Choices in Online Retail Settings N/A
Completed NCT03913871 - Text Message Program to Improve Eating Behaviors Among African Americans in New Orleans N/A
Completed NCT03698123 - Performance Nutrition for Residents and Fellows N/A
Completed NCT03941392 - Nutritional Study in Spanish Pediatric Population
Completed NCT03400566 - Effects of Experiential Learning on Vegetable Intake in Preschool Children N/A